Activity in the third quarter of 2016
(Unaudited data)
- DEVELOPMENT OF BUSINESS IN THE THIRD QUARTER (VARIATION AT CURRENT RATE)
thousands of euros
1st quarter
2nd quarter
3rd quarter
2015
2016
Var. 16/15
2015
2016
Var. 16/15
2015
2016
Var.
16/15
France
89,584
90,494
+1.0%
76,864
80,469
+4.7%
97,767
98,840
+1.1%
Europe (excluding France)
40,657
43,685
+7.4%
29,943
31,572
+5.4%
50,614
41,273
-18.5%
North America
17,193
16,064
-6.6%
12,894
14,113
+9.5%
16,055
16,020
-0.2%
Other countries
4,622
3,846
-16.8%
3,816
4,061
+6.4%
3,594
3,280
-8.7%
Group total
152,056
154,089
+1.3%
123,517
130,215
+5.4%
168,030
159,413
-5.1%
thousands of euros
1st quarter
2nd quarter
3rd quarter
2015
2016
Var. 16/15
2015
2016
Var. 16/15
2015
2016
Var.
16/15
Non-proprietary Homeopathic Medicines
79,191
80,147
+1.2%
74,354
76,001
+2.2%
73,677
73,913
+0.3%
OTC Specialties
72,880
73,743
+1.2%
49,030
53,719
+9.6%
94,328
85,319
-9.6%
Other
-15
199
-
133
495
+272.2%
25
181
+624.0%
Group total
152,056
154,089
+1.3%
123,517
130,215
+5.4%
168,030
159,413
-5.1%
- CUMULATIVE ACTIVITY AS OF THE END OF SEPTEMBER 2016
thousands of euros
2015
2016
Variation at current exchange rates
Variation at constant exchange rates
France
264,215
269,803
+2.1%
+2.1%
Europe (excluding France)
121,214
116,530
-3.9%
-1.0%
North America
46,142
46,197
+0.1%
+0.9%
Other countries
12,032
11,187
-7.0%
-4.3%
Group total
443,603
443,717
+0.0%
+1.0%
thousands of euros
2015
2016
Variation at current exchange rates
Variation at constant exchange rates
Non-proprietary Homeopathic Medicines
227,222
230,061
+1.2%
+1.3%
OTC Specialties
216,238
212,781
-1.6%
+0.3%
Other
143
875
+511.9%
+511.9%
Group total
443,603
443,717
+0.0%
+1.0%
-
HIGHLIGHTS OF THE THIRD QUARTER
- Sales revenue in the third quarter of 2016 was down by 5.1% in comparison to 2015 (the impact of exchange rates is not significant over the period).
- Sales are decreasing significantly in Russia and to a lesser extent in Spain and in the Czech Republic. They are increasing in France.
-
OUTLOOK
- The level of activity and profitability of the fiscal year will depend on the seasonal pathology of the fourth quarter.
- Our company still continues with the same determination the development of homeopathy in the world.
Our next update: January 26, 2017 at market close, publication of the sales revenue for the year 2016.
Person responsible for financial information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail : [email protected]
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at: www.boironfinance.com
Regulated information
Quaterly financial disclosure:
- Third Quarter Information
Full and original press release in PDF:
https://www.actusnews.com/documents_communiques/ACTUS-0-46118-cp-boiron_201016.pdf
Receive by email the next press releases of the company by registering on
www.actusnews.com, it's free
Source: Actusnews